Logo Logo
Switch Language to German
Tam, C.; Roberts, A.; Anderson, M. A.; Dawson, S. J.; Hicks, R.; Pott, C.; Westerman, D.; Burke, G.; Kamel, S.; Dreyling, M.; Dawson, M.; Seymour, J. (2016): The combination of ibrutinib and venetoclax (ABT-199) rapidly achieves complete remissions in patients with relapsed/refractory mantle cell lymphoma: Preliminary results of the phase II AIM study. In: Haematologica, Vol. 101: p. 103
Full text not available from 'Open Access LMU'.